Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 819

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 819
---
 authorised share capital of US$50,000 divided into 500,000,000 ordinary shares of par value US$0.0001 each of which 1 Ordinary Share is in issue, which is held by OmnigenicsAI Corp (the Merging Company Shareholder). CThe directors of the Constituent Companies and OmnigenicsAI deem it advisable that, and have resolved that, the Constituent Companies merge, pursuant to Part XVI of the Companies Act (Revised) and upon the terms and conditions hereinafter set forth, intending that the business carried on by the Merging Company shall, from the Effective Date (as defined below), be carried on by the Surviving Company. DOmnigenicsAI wishes to enter into this Plan solely for the purposes of clause 3.3. AGREEMENT: 1Merger Upon the terms and subject to the conditions set forth below, at the Effective Date (as defined in clause 2), the Merging Company shall be merged with and into the Surviving Company (the Merger), after which the separate existence of the Merging Company shall cease and the Surviving Company shall be the surviving entity and shall continue to operate under its current name. 2Effective Date The Merger shall be effective on the date that the Plan is registered by the Registrar of Companies for the Cayman Islands (such date being the Effective Date). 3Terms and conditions 3.1Upon the Effective Date (but not before), the rights, property, business, undertaking, goodwill, benefits, immunities and privileges of the Merging Company shall vest in the Surviving Company in accordance with Section 236(1)(b) of the Companies Act, and the Surviving Company shall become liable for and subject, in the same manner as the Merging Company, to all mortgages, charges and security interests, and all contracts, obligations, claims, debts and liabilities of the Merging Company in accordance with Section 236(1)(c) of the Companies Act. 3.2Upon the Effective Date, the Merging Company shall be struck from the Register of Companies. Annex B-1

3.3OmnigenicsAI undertakes and agrees (it being acknowledged that OmnigenicsAI will be the sole shareholder of the Surviving Company after the Merger) in consideration of the Merger to issue the Merger Consideration in accordance with the terms of the Business Combination Agreement. 4Shares 4.1The terms and conditions of converting shares in each constituent company into